Atlas Capital Investments has failed to keep making payments for an $18.4 million loan tied to a 78,200-square-foot office and research building in South San Jose.
The Saratoga-based investor has defaulted on the loan for the building at 5729 Fontanoso Way, the San Jose Mercury News reported. It’s linked to a life science tenant that apparently never occupied the building.
The lender, Santa Monica-based Evergreen Advantage, has threatened to foreclose on the mortgage and seize the 4.7-acre property.
Atlas Capital bought the property in May of last year for $27.4 million.
Two months later, Atlas leased the building to Khloris Biosciences, whose goal was to seek “a world without cancer.” Dr. Lynne Bui, co-founder and CEO of Khloris Bio, is a principal at Atlas Capital, according to the Mercury News.
It appears that the Mountain View-based Khloris Bio never moved into the building, despite declaring the South San Jose address on its website.
The Mercury News took a look and found that “weeds have choked its landscaping and garden areas, debris litters the building’s pathways and entrance, and a padlock is fixed to the front door. The lobby was dark and abandoned. Three vehicles were parked in the surface lot next to the building.”
All that remained was a sign bearing the company’s name taped to the door.
In 2018, Khloris Biosciences raised $5 million in a venture funding round, according to Crunchbase. A year later, Bayer, acting through a subsidiary, announced it had invested in Khloris.
— Dana Bartholomew
Read more
Commercial
San Francisco
Adam Neumann defaults on San Jose office building loan
Commercial
San Francisco
Lender seizes blighted office building in San Jose after default
San Francisco
Development site for 170-room San Jose hotel falls into default